| mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
KIN001-236 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0004 |
| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
| mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
0.003 |
| mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
| mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.003 |
| mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.004 |
| mRNA |
FMK |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.004 |
| mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.005 |
| mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.005 |